Tides Express | Pratt&Lyle polypeptide drug PL-3301 oral gel approved by FDA
Edited by the Peptide Biochemical Content Team On June 14, 2024, Pratt&Lyle Pharmaceuticals received the official reply from the US FDA that approved its new class 1 drug, antibacterial peptide PL-3301 oral gel, to conduct human clinical research and verification.About Antimicrobial Peptide PL-3301 Oral gel As a first in class peptide broad-spectrum antifungal and bacterial…